2025 NextGen Webinars

May 2025

Title: Delivering Pandemic Vaccines in 100 Days — What Will It Take?, 
Speaker: Dr Renske Hesselink, CEPI

Title: Advancing saRNA Delivery: Evaluating Novel PEI-Inspired Polymers as Non-Viral Carriers

Speaker: Lisa Opsomer, PhD student, Ghent University

Recording will be available shortly.

April 2025

Title: Connecting Ideas with Impact: Building Effective Academia-Industry Alliances
Speaker: Dr Balaji Somasundaram, Denteric Pty Ltd

Title: From bench to business development

Speaker: Dr Wasan Forsyth, Vaxxas Pty Ltd

Recording will be available shortly.

March 2025

Title: Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Speaker: Nicholas Tursi, University of Pennsylvania Perelman School of Medicine

Title: Exploring Galsomes, adjuvanted mRNA-LNPs, for the development of more effective vaccines against Mycobacterium tuberculosis
Speaker: Ilke Aernout, Ghent University

Recording will be available shortly.

February 2025

TITLE: Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination
Speaker: Dr. James Allen, Cleveland Clinic


Mentoring Session: Setting Up an Academic Lab; Opportunities and Challenges
Speaker: Dr. Michael SchotsaertIcahn School of Medicine at Mount Sinai

January 2025

TITLE: Improving Humoral Immunogenicity of Adenoviral Vector Vaccines by Capsid Display

Speaker: Alexander Sampson, Oxford University (Winner of 2024 ISV Annual Congress Bright Sparks Competition)


TITLE: Entrepreneurship and Biotech Start-Up
Speaker: Dr. Manon Cox, Chief Executive Officer & Co-Founder at NextWaveBio

2024 NextGen Webinars


December 2024

Peripheral co delivery of plasmid encoded mucosal chemokine CCL27 enhances mucosal immunity and supports protection from heterologous SARS CoV 2 and H5N1 influenza virus challenges

Speaker: Dr. Ebony Gary, The Wistar Institute

Industry Session: Computational Vaccinology

November 2024

Speaker: Dr. Sandra Depelsenaire, Vaxxas

September 2024

Skills and Opportunities for Early Career Researchers in the Biomedical Industry

The International Society for Vaccines is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines and immunotherapeutics.  The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
info@isv-online.org  /  ISV Annual Congress